Dennis Egger, Edward Miguel, Shana S. Warren, Ashish Shenoy et al.
Despite numerous journalistic accounts, systematic quantitative evidence on economic conditions during the ongoing COVID-19 pandemic remains scarce for most low- and middle-income countries, partly due to limitations of official economic statistics in environments with large informal sectors and sub...
Samarasimha Reddy N, Nayana P. Nair, Jacqueline E. Tate, Varunkumar Thiyagarajan et al.
BACKGROUND: A three-dose, oral rotavirus vaccine (Rotavac) was introduced in the universal immunization program in India in 2016. A prelicensure trial involving 6799 infants was not large enough to detect a small increased risk of intussusception. Postmarketing surveillance data would be useful in a...
Nathan Barker, C. Austin Davis, Paula López-Peña, Harrison Mitchell et al.
Using detailed microdata, we document how migration-dependent households are especially vulnerable during the COVID-19 pandemic. We create pre- and post-COVID panel datasets for three populations in Bangladesh and Nepal, leveraging experimental and observational variation in prior migration dependen...
Kshitij Jagtap, R Naveen, Jessica Day, Parikshit Sen et al.
OBJECTIVE: Flares of autoimmune rheumatic diseases (AIRDs) following COVID-19 vaccination are a particular concern in vaccine-hesitant individuals. Therefore, we investigated the incidence, predictors and patterns of flares following vaccination in individuals living with AIRDs, using global COVID-1...
Parikshit Sen, R Naveen, Nazanin Houshmand, Siamak Moghadam‐Kia et al.
OBJECTIVE: COVID-19 vaccines have a favorable safety profile in patients with autoimmune rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however, hesitancy continues to persist among these patients. Therefore, we studied the prevalence, predictors and reasons for hesita...
Nathan Barker, C. Austin Davis, Paula López-Peña, Harrison Mitchell et al.
This study explores the relationship between migration and household resilience during a global crisis that eliminated the option to migrate. We link prior data from four populations in Bangladesh and Nepal to new phone surveys conducted during the early months of the COVID-19 pandemic. While earnin...
Bohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, Jessica Day et al.
Limited evidence on long-term COVID-19 vaccine safety in patients with idiopathic inflammatory myopathies (IIMs) continues to contribute to vaccine hesitancy. We studied delayed-onset vaccine adverse events (AEs) in patients with IIMs, other systemic autoimmune and inflammatory disorders (SAIDs), an...
R Naveen, Parikshit Sen, Zoltán Griger, Jessica Day et al.
OBJECTIVES: Disease flares in the post-coronavirus disease 2019 (COVID-19) vaccination period represent a prominent concern, though risk factors are poorly understood. We studied these flares among patients with idiopathic inflammatory myopathies (IIMs) and other autoimmune rheumatic diseases (AIRDs...
R Naveen, Darpan R. Thakare, Masataka Kuwana, John D Pauling et al.
The safety profile of COVID-19 vaccines is understudied in patients with systemic sclerosis (SSc). We compared short-term adverse events (AEs) 7 days following vaccination in patients with SSc vs other rheumatic (AIRDs), non-rheumatic autoimmune diseases (nrAIDs), and healthy controls (HCs). The COV...
Sasha Saadia Ali, R Naveen, Parikshit Sen, Jessica Day et al.
[No abstract]
Alessia Alunno, Francesco Carubbi, Ai Lyn Tan, Parikshit Sen et al.
Notwithstanding the wealth of literature on COVID-19, studies focusing on young adults with autoimmune diseases (AD) are lacking. To determine early (within 7 days) and late (after 7 days) anti-SARS-CoV-2 vaccine-related adverse events (AEs), post-vaccine disease flares, COVID-19 severity and breakt...
Akira Yoshida, Yuan Li, Vahed Maroufy, Masataka Kuwana et al.
Abstract Objectives To investigate health-related quality of life in patients with idiopathic inflammatory myopathies (IIMs) compared with those with non-IIM autoimmune rheumatic diseases (AIRDs), non-rheumatic autoimmune diseases (nrAIDs) and without autoimmune diseases (controls) using Patient-Rep...
Mrinalini Dey, R Naveen, Elena Nikiphorou, Parikshit Sen et al.
[No abstract]
C. Sieiro Santos, J. P. Chen, Elena Nikiphorou, Chih‐Wei Tseng et al.
COVID-19 has been suggested as a possible trigger of disease flares in patients with rheumatoid arthritis (RA). However, factors associated with disease flares remain unknown. This study aimed to identify factors associated with breakthrough infection (BIs) and disease flares in patients with RA fol...
Marco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, Florenzo Iannone et al.
OBJECTIVE: The presence of comorbidities can substantially affect patients' quality of life, but data regarding their impact on idiopathic inflammatory myopathies (IIMs) are limited. METHODS: We examined the prevalence of comorbidities in IIM patients, other autoimmune rheumatic diseases (oAIRDs) an...